Charity of the week: Melanoma Research Foundation

The Melanoma Research Foundation is the world’s largest independent organization devoted to addressing melanoma.

The Melanoma Research Foundation (melanoma.org) is the world’s largest independent organization devoted to addressing melanoma, the fastest-growing form of skin cancer. The MRF supports medical research to find effective treatments and eventually a cure for melanoma, which can also occur in the eyes, in mucous membranes, and beneath fingernails and toenails. As well as educating patients and physicians about the prevention, diagnosis, and treatment of melanoma, the MRF advocates for the melanoma community and raises awareness of the disease. It urges everyone to check their skin regularly for suspicious moles or lesions and to apply sunscreen, since most melanomas are attributed to exposure to ultraviolet light. The MRF’s website is the premier source for those seeking information about melanoma.

Each charity we feature has earned a four-star overall rating from Charity Navigator, which rates not-for-profit organizations on the strength of their finances, their control of administrative and fundraising expenses, and the transparency of their operations. Four stars is the group’s highest rating.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us